What is the current Global Psoriasis Drugs Market size?

The Global Psoriasis Drugs Market is projected to register a CAGR of 9.89% during the forecast period (2024-2029) Read More

Who are the key players in Global Psoriasis Drugs Market?

Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG and Amgen Inc. are the major companies operating in the Global Psoriasis Drugs Market. Read More

Which is the fastest growing region in Global Psoriasis Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Psoriasis Drugs Market?

In 2024, the North America accounts for the largest market share in Global Psoriasis Drugs Market. Read More

What years does this Global Psoriasis Drugs Market cover?

The report covers the Global Psoriasis Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Psoriasis Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Psoriasis Drugs Market Size & Share Analysis - Industry Research Report

Psoriasis Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Psoriasis Drugs Market is Segmented by Type of Treatment (Biologic Drugs, Small Molecule Systemic Drugs, and Tropical Therapies), Mechanism of Action (TNF Alpha Inhibitors, PDE4 Inhibitors, Interleukin Inhibitors, and Other Mechanisms of Action), Route of Administration (Oral, Parenteral, and Topical), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (USD million) for the above segments.

Psoriasis Drugs Industry Overview

The psoriasis drugs market is moderately competitive and consists of several key players. Concerning the market share, few of the key players currently dominate the market. Companies are focusing on business expansion in developing regions or emerging markets, such as India, China, and South Korea, by adopting strategies, including alliances and acquisitions, to develop novel products. Some of the major players operating in the market include AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen Idec, Boehringer Ingelheim, Celgene Corporation, Dr. Reddy`s Laboratories, Eli Lilly and Company, Forward Pharma, Johnson and Johnson (Janssen Biotech Inc.), Leo Pharma AS, Merck and Co. Inc., Novartis AG and Pfizer Inc. among others.